These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10588737)

  • 1. Identification and classification of p53-regulated genes.
    Yu J; Zhang L; Hwang PM; Rago C; Kinzler KW; Vogelstein B
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14517-22. PubMed ID: 10588737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse DDA3 gene is a direct transcriptional target of p53 and p73.
    Hsieh SC; Lo PK; Wang FF
    Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the p53-homologue p73 in E2F1-induced apoptosis.
    Stiewe T; Pützer BM
    Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
    Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
    Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis.
    Dohn M; Jiang J; Chen X
    Oncogene; 2001 Oct; 20(45):6503-15. PubMed ID: 11641774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ribonucleotide reductase gene is a transcriptional target of p53 and p73.
    Nakano K; Bálint E; Ashcroft M; Vousden KH
    Oncogene; 2000 Aug; 19(37):4283-9. PubMed ID: 10980602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73.
    Krause K; Haugwitz U; Wasner M; Wiedmann M; Mössner J; Engeland K
    Biochem Biophys Res Commun; 2001 Jun; 284(3):743-50. PubMed ID: 11396965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
    Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
    Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement.
    Rödicker F; Pützer BM
    Cancer Res; 2003 Jun; 63(11):2737-41. PubMed ID: 12782576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 and p53 pathway in human breast cancers.
    Bozzetti C; Nizzoli R; Musolino A; Martella EM; Crafa P; Lagrasta CA; Camisa R; Bonati A; Lunghi P; Ardizzoni A
    J Clin Oncol; 2007 Apr; 25(11):1451-3; author reply 1453-4. PubMed ID: 17416871
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour-suppressor genes. Killer in search of a motive?
    Clurman B; Groudine M
    Nature; 1997 Sep; 389(6647):122-3. PubMed ID: 9296483
    [No Abstract]   [Full Text] [Related]  

  • 19. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
    Zaika AI; Kovalev S; Marchenko ND; Moll UM
    Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.
    Liu G; Chen X
    Oncogene; 2002 Oct; 21(47):7195-204. PubMed ID: 12370809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.